Catheter Precision (VTAK) Depreciation & Amortization (CF) (2020 - 2026)

Catheter Precision (VTAK) has reported Depreciation & Amortization (CF) for 7 consecutive years, with $382000.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Depreciation & Amortization (CF) fell 21.24% year-over-year to $382000.0 in Q2 2026; TTM through Jun 2026 was $1.9 million, a 9.2% decrease from a year earlier, with the FY2025 full-year figure at $2.1 million, changed 0.28% from the prior year.
• Depreciation & Amortization (CF) was $382000.0 for Q2 2026 at Catheter Precision, down from $405000.0 in the prior quarter.
• Over five years, Depreciation & Amortization (CF) peaked at $1.4 million in Q1 2023 and troughed at -$406000.0 in Q2 2023.
• A 5-year average of $417055.6 and a median of $518500.0 in 2023 frame the typical range for Depreciation & Amortization (CF).
• The widest YoY moves for Depreciation & Amortization (CF): up 1968.0% in 2023, down 398.53% in 2023.
• Over 5 years, Depreciation & Amortization (CF) stood at $25000.0 in 2022, then jumped by 1968.0% to $517000.0 in 2023, then grew by 2.71% to $531000.0 in 2024, then declined by 0.75% to $527000.0 in 2025, then fell by 27.51% to $382000.0 in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $382000.0 (Q2 2026), $405000.0 (Q1 2026), and $527000.0 (Q4 2025), per Business Quant data.